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Cystic ﬁbrosis is the most common fatal autosomal recessive multisystem disorder,
which occurs mainly in European-derived populations. There are currently more
than 1500 mutations. DF508, which is a deletion of the phenylalanine at position
508, is the most common mutation. The R347P is a rare missense mutation located
within the ﬁrst membrane spanning domain (MSD1) of the CFTR protein. This
mutation occurs with an overall worldwide frequency of about 0.2%. L812X, 3608
ins G and 1853C mutations have not been reported yet in cystic ﬁbrosis patients.
Here; we report three Turkish children who were diagnosed to have cystic ﬁbrosis
based on characteristic manifestations of cystic ﬁbrosis and pathological sweat test
results. By the genetic analysis, in case 1, R347P mutation was identiﬁed in a
compound heterozygote state with a novel mutation, L812X. In case 2 and 3, 3608
ins G and 1853C mutations were respectively determined.
2* Identiﬁcation of two Alu insertions in the CFTR gene
M.P. Audrezet1, E. Masson1, M. Macek3, O. Raguenes1, B. Fercot1, J.M. Chen2,
C. Fe´rec1,2. 1Genetique Moleculaire, CHU-INSERM, Brest, France; 2EFS-
Bretagne, Brest, France; 3Institute of Biology and Medical Genetics, Prague,
Czech Republic
LINE-1 (long interspersed element-1) or L1-mediated retrotransposition is a potent
force in human genome evolution and an occasional cause of human genetic disease.
Since the ﬁrst report of two de novo L1 insertions in the F8 gene causing hemophilia
A, more than 50 L1-mediated retrotranspositional events have been identiﬁed as
causing human genetic disease.
On the basis of the observation that both L1 elements and Alu sequences are abun-
dant in the human genome, the increasing number of large genomic rearrangements
reported in the CFTR gene, and the fairly large size of the CFTR gene, we surmised
that some previously unresolved cystic ﬁbrosis chromosomes might carry hitherto
undetected L1-mediated retrotranspositional insertions.
This study therefore report the detection and the characterization of two simple Alu
insertions using quantitative high-performance liquid chromatography (QHPLC),
technique previously employed to delineate the boundaries of large genomic
deletions in the CFTR gene.
The ﬁrst one, identiﬁed in a 24-year-old French girl, carrying F508del on the other
chromosome, corresponds to a 103 bp antisense insertion in exon 16 containing an
Alu sequence of 46 bp and a poly(A) tail of 57 bp. The second one, identiﬁed in
a 28-year-old Czech man with typical cystic ﬁbrosis, correspond to a 337 bp sense
insertion of an Alu sequence of 281 bp and a poly(A) tail of 56 bp. Both mutations
are presumed to lead to aberrant splicing.
The identiﬁcation of these two simple Alu insertions in the CFTR gene not only
revealed a previously unknown mutational mechanism responsible for cystic ﬁbrosis
but also represents an important addition to the already diverse spectrum of CFTR
gene mutations.
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CF is still thought of as a rare disease in black Africans with an estimated incidence
of 1 in 12,000 to 1 in 15,000 and minimal information is available concerning the
spectrum of CFTR mutations in this population. Extensive screening of 12 patients
for CFTR mutations using DGGE and sequencing of abnormal patterns resulted
in the detection of 62.5% of the molecular defects (3120+1G>A, p.Gly1249Glu,
2183delAA, 3196del54, −94G>T): 6 homozygous or compound heterozygous, 3
heterozygous and 3 without mutation.
Patients with unidentiﬁed alleles were subsequently tested for large rearrangements
using a semi-quantitative ﬂuorescent PCR assay. A deletion of exon 2 was found
in a patient heterozygous for the most common mutation in this population
(3120+1G>A). Mapping and sequencing the breakpoint junction revealed that the
large deletion [c.54−1161_c.164+1603del2875] was different from the deletion of
exon 2 [c.54−5811_c.164+2186del8108ins182] previously described in Caucasian
patients. The mutational mechanism could be explained by a classical model of
replication slippage due to direct repeats present at the 5’ and 3’ breakpoints. Un-
resolved alleles may have mutations in non-coding CFTR regions not investigated;
however, the lack of mutation detection in 3 patients without consanguinity could
result from the contribution of other gene(s) or to misdiagnosis due to false positive
sweat test results that may be more common in some populations.
This study emphasizes the importance of scanning the entire CFTR gene and
including a search for gross rearrangements in CF diagnosis.
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The aim of our study was to describe a mutation spectrum of the CFTR gene in
CF patients from Moscow region. At present day in Moscow centre of CF are
registrated 178 patients (aged 2 months – 18 years) from Moscow and Moscow
province. Genotypes were tested in 169 children with CF (including 5 patients on
National program of newborn screening on CF, started in 2006). The median age
of genetic diagnosis is 3.8 years (q25 = 1.0, q75 = 7.3).
DNA analysis on CFTR mutations in Russian Centre for Medical Genetics is per-
formed routinely from 1990. Now it is possible to deﬁne 23 CFTR gene mutations,
among which we found 14 mutations in Moscow region young patients (338 alleles):
DF508 – 60.3%, CFTRdele2,3(21kb) 9.2%, W1282X 2.6%, 2143delTT 2.1%,
N1303K 1.7%, G542X 1.7%, 3849+10kbC→T 1.5%, 2184insA 1.2%, 677delTA
0.6%, L138insA 0.6%, 604insA 0.6%, R334W 0.6%, 3821delT 0.3%, 394delTTex3
0.3%. 17.1% of CFTR alleles are not identiﬁed, this index is lower, than on the
whole Russia (26.6%). Most probably, it is explained by a multi-ethnic society. In
our days there is a necessity to expander the mutation panel, that will allow to
create the «Slavic» panel on the one hand, and the multinational panel for different
ethnic groups in Russia on the other hand. It will help to improve a quality of
screening, especially in doubtful cases.
